P240022/S005: Evolysse Smooth; Evolysse Form
FDA’s recorded scope: a semi-automated finger grip assembly process
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 4 FDA records to the applicant name Symatese. 3 entries are PMA supplements. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Sep 3, 2025 to Feb 27, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code LMH appears in 4 of the 4 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P240022, with 4 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: Zi Les Troques, Chaponost, 69630. Recorded on P240022/S005, decision dated Feb 27, 2026.
FDA’s recorded scope: a semi-automated finger grip assembly process
FDA’s recorded scope: Approval for a design change to the syringe plunger rod for the Evolysse injectable hyaluronic acid gels approved under P240022
FDA’s recorded scope: Approval for changes to the Informed Consent Form used in the Post-Approval Study.
FDA’s recorded scope: approval of the protocol for the post-approval study (PAS).
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.